NEWTYN MANAGEMENT, LLC Talis Biomedical Corporation Transaction History

NEWTYN MANAGEMENT, LLC portfolio value:

$0
portfolio value

NEWTYN MANAGEMENT, LLC quarter portfolio value change:

-16.06%
quarter

Talis Biomedical Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -284.72K shares -231K $0.68 0
Q2 2022 share Increase 0.00% 284.72K shares 231K $0.81 284.72K